AI-generated evidence in drug discovery: reliability, legal risk and FDA compliance

Oct 19, 2026 · Issue 12 · 2 sources, 2 articles

A Crowell & Moring legal analysis discusses the risk of faulty but credible-looking citations from AI models used in drug discovery, and FDA compliance.

Who is affected and how

pharmaceuticals

AI-generated citations and results must be handled with documented verification before they enter submission materials.

Sources

• AI-Generated Evidence in Drug Discovery: Reliability, Legal Risk & FDA Compliance | Crowell & Moring | Crowell & Moring LLPcrowell.com · Oct 19, 2026
• AI-Generated Evidence in Drug Discovery: Reliability, Legal Risk & FDA Compliancecrowell & moring llp · Oct 21, 2026

Machine-generated summary based on the titles and excerpts of the source articles. The source article is the authority for the facts. News monitoring, not medical advice: consult a doctor for health decisions.